Musk’s Neuralink says second trial implant went well, no thread retraction issue 

(Reuters) – Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial patient.  The company said the patient, identified as Alex, did not face issues of “thread retraction”, unlike Noland Arbaugh, Neuralink’s first patient who received the…

Read More